Ihi Corporation

Other

Hideo Naganuma

Motonao Niizuma

Jun Araki

Susumu Tokura

Eiichi Urushibata

Teruhiko Inoue

Fumitoshi Asai

Taketoshi Ogawa

Naotoshi Yamamura

Kazuyoshi Nakamura

According to an embodiment, a management system manages a power transmitter capable of wirelessly transmitting power to a power receiver of a movable object. The management system includes a detection unit configured to detect a state of the power transmitter, a storage unit configured to store a relationship between the state of the power transmitter and a power transmission level indicating possibility of power transmission of the power transmitter, an identification unit configured to identify the power transmission level corresponding to the state detected by the detection unit, and an output unit configured to output the identified power transmission level before the power transmitter starts transmitting power. The power transmission level includes at least an unavailable level indicating that power transmission is impossible, a limitation level indicating that power transmission is possible under a predetermined limitation, and a normal level indicating that power transmission is possible without limitation.

System, method, and program for managing power transmission device

A cooling system includes a cooling unit configured to cool at least one of a power reception unit configured to wirelessly receive power from a power transmission unit and a power storage unit configured to store the power received by the power reception unit; and a controller configured to control the cooling unit. The cooling unit is operated by the power received by the power reception unit, and the controller controls the cooling unit on the basis of a necessary amount of charge of the power storage unit.

Cooling system and wireless power transfer system

Acid addition salts of 2-acetoxy-5-(&agr;-cyclopropyl-carbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno&lsqb;3,2-c&rsqb;-pyridine. The acid addition salts of tetrahydrothienopyridine derivatives of the present invention exhibit excellent oral absorption, metabolization into the active compound, and platelet aggregation-inhibiting effects, low toxicity, and excellent storage and handling stabilities, and are useful as medicaments, preferably preventive or therapeutic agents (particularly therapeutic agents) for diseases caused by a thrombus or an embolus, still more preferably preventive or therapeutic agents (particularly therapeutic agents) for thrombosis or embolism.

Acid addition salts of hydropyridine derivatives

Growing community of inventors

Tokyo, Japan

Hideo Naganuma